Stopping screening, when and how?

Screening for prostate cancer (PC) is still controversial despite randomized trials has found that PC mortality is decreased. The major concern is the high rate of over-diagnosis and subsequent harms that may follow in many men who never would have had any symptoms during life-time if not screened....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Translational Andrology and Urology 2018-02, Vol.7 (1), p.46-53
1. Verfasser:	Hugosson, Jonas
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Cancer and Oncology Cancer och onkologi Epidemiology Folkhälsovetenskap, global hälsa och socialmedicin Over-diagnosis Prostate cancer (PC) Public Health, Global Health and Social Medicine Review Screening
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!